Health · 1 sources covering this

STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

Europe pulls Tavneos over trial integrity concerns, pricing concerns over AstraZeneca's hypertension drug, and more biotech news from The Readout

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit
Europe pulls Tavneos over trial integrity concerns, pricing concerns over AstraZeneca's hypertension drug, and more biotech news from The Readout
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/283fc3e8c74bda08fccefef5736a007e05355751"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Akeso and Summit&#8217;s lung cancer drug shows worsening tumor-progression benefit"></iframe>

STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

How 1 sources are covering this

STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

More from Health

STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more

Everything the Trump administration did on health care last week

Cialis is an erectile dysfunction drug. Could it also help you live longer?

Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Akeso and Summit&#8217;s lung cancer drug shows worsening tumor-progression benefit

More from Health

STAT+: Pharmalittle: We&#8217;re reading about an AstraZeneca setback, falling U.S. drug prices, and more

Everything the Trump administration did on health care last week

Cialis is an erectile dysfunction drug. Could it also help you live longer?

Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start

Reader

Trust & legal

Across the network

STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more